Generalizability in two clinical trials of Lyme disease - PMC
The Klempner et al. trials on chronic Lyme disease treatment's generalizability is questioned due to a select patient group, potentially limiting applicability to broader populations. The review highlights the trials' failure to address treatment delays and previous antibiotic courses, suggesting these factors may influence outcomes.
Reference News
Generalizability in two clinical trials of Lyme disease - PMC
The Klempner et al. trials on chronic Lyme disease treatment's generalizability is questioned due to a select patient group, potentially limiting applicability to broader populations. The review highlights the trials' failure to address treatment delays and previous antibiotic courses, suggesting these factors may influence outcomes.